Venture Capital

As Disc Medicine nears a potential drug launch, its new HR chief hire reveals a critical strategy for navigating biotech's intense talent wars.

Sonos adds leaders from Meta, e.l.f. Beauty, and Pandora to its board, signaling a strategic push into AI, platform growth, and financial discipline.

The biotech firm faces a delisting threat after its equity turned negative. Can recent funding save its Nasdaq spot and its ambitious drug pipeline?

The AI health-tech leader achieved profitability and massive growth in 2025, expanding its reach to nearly 2,000 hospitals and doubling its life sciences arm.

The investment firm celebrated a strong 2025 with shareholder payouts, fueled by profitable exits and a new major investment in AI infrastructure firm TensorWave.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

OpenText divests its on-premise eDOCS unit to NetDocuments, using the cash for debt reduction while sharpening its focus on AI and cloud services.

Cosmetics brand Sorevna is diving into the crowded bath and body sector, promising a revolutionary launch. But can its science-first approach succeed?

1X just unveiled a new AI model letting its NEO humanoid learn from internet videos, blurring the line between digital AI and physical reality. But is the world ready?

Juvena Therapeutics lands a $33.5M Series B and a major pharma deal to advance its AI-discovered regenerative drugs for neuromuscular diseases.

ProductPlan acquires AI-native Winware.ai, naming founder Steven Cohn its new CEO to forge an intelligence platform aimed at ending product uncertainty.

Just weeks after a blockbuster IPO, travel tech firm Navan is under investigation for misleading investors as its stock plummets and its CFO departs.

With new executive leadership, AI firm HealthLeap aims to accelerate its mission of improving patient outcomes and hospital finances nationwide.

Fullscript and ŌURA are integrating biometric data into clinical workflows, promising a new era of personalized medicine. But is healthcare ready for it?

As AI costs soar, Hammerspace gains industry validation for its dynamic data platform that maximizes GPU power while slashing cloud storage expenses.

LyfeSci's acquisition of Clinically Media aims to fix the clinical trial bottleneck by integrating patient recruitment, promising faster, more diverse studies.

Sweden secures sovereign satellite capabilities in a 9-figure deal, signaling a new era of European defense autonomy and disrupting the space industry.

Following a $25M fundraise, former WA Health Secretary Dr. Shah joins Jaan Health, signaling a new era for AI-driven chronic disease management.

With AI agents creating a new security frontier, 1Password appoints former AWS exec Nancy Wang as CTO to build the 'trust layer' for non-human identities.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.